Literature DB >> 22998029

The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization.

Leyla Asena, Yonca A Akova, Altug Cetinkaya, Cem Kucukerdonmez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22998029     DOI： 10.1111/j.1755-3768.2012.02540.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  5 in total

1.  Topical bevacizumab treatment in aniridia.

Authors:  Ruth Lapid-Gortzak; Nathalie T Y Santana; Carla P Nieuwendaal; Maarten P Mourits; Ivanka J E van der Meulen
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

2.  Topical Bevacizumab for the Treatment of Ocular Surface Squamous Neoplasia.

Authors:  Leyla Asena; Dilek Dursun Altınörs
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-26       Impact factor: 2.671

3.  Clinical Findings, Follow-up and Treatment Results in Patients with Ocular Rosacea.

Authors:  İlkay Kılıç Müftüoğlu; Yonca Aydın Akova
Journal:  Turk J Ophthalmol       Date:  2016-01-05

4.  Functional Staging of Corneal Neovascularization Using Fluorescein and Indocyanine Green Angiography.

Authors:  Christoph Palme; Vito Romano; Matthias Brunner; Riccardo Vinciguerra; Stephen B Kaye; Bernhard Steger
Journal:  Transl Vis Sci Technol       Date:  2018-10-01       Impact factor: 3.283

5.  Comparison of the Therapeutic Efficacies of Topical Rivoceranib and Topical Bevacizumab in a Murine Model of Corneal Neovascularization.

Authors:  Hyeon Jeong Yoon; Je Moon Woo; Yong Sok Ji; Kyung Chul Yoon
Journal:  Medicina (Kaunas)       Date:  2019-11-07       Impact factor: 2.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.